Table 2.
PREMIER study - outcome at 2 years follow-up[13]
| Ada + MTX | Ada | MTX | |
| ACR20 | 69% | 49% | 56% |
| ACR50 | 59% | 37% | 43% |
| ACR70 | 47% | 28% | 28% |
Ada: Adalimumab; MTX: Methotrexate.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.